Jordt M. Raymond's Insider Trades & SAST Disclosures
Jordt M. Raymond's most recent trade in Altimmune Inc was a trade of 2,614 Common Stock, par value $0.0001 done at an average price of $5.2 . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jordt M. Raymond.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 5.18 per share. | 31 Jan 2025 | 2,614 | 34,902 (0%) | 0% | 5.2 | 13,541 | Common Stock, par value $0.0001 |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 183,600 | 183,600 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2025 | 63,400 | 63,400 | - | - | Restricted Stock Units | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2025 | 14,600 | 43,800 | - | - | Restricted Stock Units | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2025 | 14,600 | 36,150 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.98 per share. | 25 Jan 2025 | 3,862 | 32,288 (0%) | 0% | 7.0 | 26,957 | Common Stock, par value $0.0001 |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 9,375 | 24,035 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 9,375 | 18,750 | - | - | Restricted Stock Units | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.21 per share. | 01 Jan 2025 | 2,485 | 21,550 (0%) | 0% | 7.2 | 17,917 | Common Stock, par value $0.0001 |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 5.41 per share. | 31 Jul 2024 | 917 | 14,660 (0%) | 0% | 5.4 | 4,961 | Common Stock, par value $0.0001 |
| Altimmune Inc | M. Raymond Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 2.69 per share. | 31 Jan 2024 | 5,030 | 13,743 (0%) | 0% | 2.7 | 13,531 | Common Stock, par value $0.0001 |
| Altimmune Inc | Raymond Jordt M. | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 163,200 | 163,200 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Raymond Jordt M. | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 58,400 | 58,400 | - | - | Restricted Stock Units | |
| Altimmune Inc | Jordt M. Raymond | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 9,375 | 28,125 | - | - | Restricted Stock Units | |
| Altimmune Inc | Jordt Raymond M. | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 9,375 | 11,207 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | Raymond Jordt M. | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.25 per share. | 01 Jan 2024 | 2,503 | 8,704 (0%) | 0% | 11.3 | 28,159 | Common Stock, par value $0.0001 |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 2.81 per share. | 31 Jul 2023 | 1,832 | 1,832 (0%) | 0% | 2.8 | 5,148 | Common Stock, par value $0.0001 |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 125,000 | 125,000 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Raymond M. Jordt | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 37,500 | 37,500 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges